GE HealthCare Reports First Quarter 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
BofA thinks the selloff in GE HealthCare (GEHC) may be overdone. Here's why
May 1, 2024 12:30 PM EDTFollowing a surprising miss in revenue and earnings per share (EPS) for the first quarter, shares of GE HealthCare (NASDAQ: GEHC) experienced a significant downturn, plummeting over 14% on Tuesday. The miss, which caught investors off guard, was driven by unexpected disruptions in China and a more pronounced second half ramp.
Despite the... More
GE HealthCare (GEHC) PT Lowered to $96 at Evercore ISI
April 30, 2024 12:05 PM EDTEvercore ISI analyst Vijay Kumar lowered the price target on GE HealthCare (NASDAQ: GEHC) to $96.00 (from $100.00) while maintaining a Outperform rating.
The analyst comments "GEHC reported org rev declines of -50 bps, with revs of $4.65 Bn coming in ~150M or 3% below ST. The miss was mainly driven by lower capital sales (MRI, CT, ultrasound & monitoring/vents) and was partly offset by better PDx. Geographically, the miss was driven by China as customers paused due to stimulus announcement. 1Q also had some order fulfillment issues in its PCS segment. On the positive side, GMs were up... More
